GLAXO SMITH KLINEGG

GLAXO SMITH KLINE

41.180EGPD
+0.760+1.88%
At close at Jun 4, 11:29 GMT
EGP
No trades
See on Supercharts

BIOC fundamentals

GLAXO SMITH KLINE financial statements, including revenue, expenses, and profit

The annual and quarterly earnings report below will help you understand the performance of BIOC.

Q4 '14
Q1 '15
Q2 '15
Q3 '15
Q4 '15
Q1 '16
Q2 '16
Q3 '16
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q1 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−250.00 M‬‬
‪0.00‬
‪‪250.00 M‬‬
‪‪500.00 M‬‬
‪‪750.00 M‬‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EGP
Q4 '14
Dec 2014
Q1 '15
Mar 2015
Q2 '15
Jun 2015
Q3 '15
Sep 2015
Q4 '15
Dec 2015
Q1 '16
Mar 2016
Q2 '16
Jun 2016
Q3 '16
Sep 2016
Q4 '16
Dec 2016
Q1 '17
Mar 2017
Q2 '17
Jun 2017
Q3 '17
Sep 2017
Q4 '17
Dec 2017
Q1 '18
Mar 2018
Q3 '18
Sep 2018
Q4 '18
Dec 2018
Q1 '19
Mar 2019
Q2 '19
Jun 2019
Q3 '19
Sep 2019
Q1 '20
Mar 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q1 '24
Mar 2024
Q2 '24
Jun 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
TTM
Total revenueYoY growth
‪‪346.60 M‬‬
+9.28%
‪‪460.66 M‬‬
+1.14%
‪‪539.66 M‬‬
+31.37%
‪‪576.44 M‬‬
+53.42%
‪‪713.81 M‬‬
+105.94%
‪‪−252.55 M‬‬
‪‪−351.03 M‬‬
‪‪−425.82 M‬‬
‪‪−406.72 M‬‬
‪‪−388.17 M‬‬
Gross profitYoY growth
‪‪94.05 M‬‬
−34.83%
‪‪109.63 M‬‬
−19.47%
‪‪113.83 M‬‬
−35.19%
‪‪169.71 M‬‬
+54.70%
‪‪325.64 M‬‬
+246.25%
‪‪−97.90 M‬‬
‪‪−74.66 M‬‬
‪‪−104.68 M‬‬
‪‪−64.54 M‬‬
‪‪−249.32 M‬‬
‪‪−3.86 M‬‬
−111.03%
‪‪34.98 M‬‬
+9.25%
‪‪9.16 M‬‬
−83.15%
‪‪105.17 M‬‬
+100.14%
‪‪76.32 M‬‬
‪‪17.65 M‬‬
‪‪−13.40 M‬‬
‪‪−2.13 M‬‬
‪‪−57.64 M‬‬
‪‪−71.38 M‬‬
Pretax incomeYoY growth
‪‪13.79 M‬‬
+212.81%
‪‪21.57 M‬‬
+12.56%
‪‪7.03 M‬‬
−85.32%
‪‪47.53 M‬‬
+160.89%
‪‪4.94 M‬‬
−64.20%
‪‪−11.15 M‬‬
‪‪−7.76 M‬‬
‪‪−1.26 M‬‬
‪‪−20.37 M‬‬
‪‪−13.93 M‬‬
‪‪−2.18 K‬‬
‪−898.00‬
‪‪−4.25 K‬‬
‪‪−5.54 K‬‬
‪‪−3.65 K‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪2.64 M‬‬
‪‪13.81 M‬‬
‪‪5.76 M‬‬
‪‪27.16 M‬‬
‪‪−8.99 M‬‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
Net incomeYoY growth
‪‪2.64 M‬‬
−1.98%
‪‪13.81 M‬‬
−23.05%
‪‪5.76 M‬‬
−88.23%
‪‪27.16 M‬‬
−46.92%
‪‪−8.99 M‬‬
−440.07%
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪0.00‬
‪‪2.64 M‬‬
‪‪13.81 M‬‬
‪‪5.76 M‬‬
‪‪27.16 M‬‬
‪‪−8.99 M‬‬
‪0.03‬
−1.86%
‪0.17‬
−23.03%
‪0.07‬
−88.23%
‪0.33‬
−46.91%
‪−0.11‬
−439.43%
‪0.03‬
−1.86%
‪0.17‬
−23.03%
‪0.07‬
−88.23%
‪0.33‬
−46.91%
‪−0.11‬
−439.43%
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
‪‪83.51 M‬‬
EBITDAYoY growth
‪‪8.10 M‬‬
−82.92%
‪‪46.82 M‬‬
−1.43%
‪‪20.96 M‬‬
−70.38%
‪‪117.12 M‬‬
+76.98%
‪‪89.04 M‬‬
+998.68%
EBITYoY growth
‪‪−3.86 M‬‬
−111.03%
‪‪34.98 M‬‬
+9.25%
‪‪9.16 M‬‬
−83.15%
‪‪105.17 M‬‬
+100.14%
‪‪76.32 M‬‬
‪‪−350.46 M‬‬
‪‪−425.68 M‬‬
‪‪−530.50 M‬‬
‪‪−471.27 M‬‬
‪‪−637.49 M‬‬